The Ayurvedic Institute. The Ancient Ayurvedic Writings. Available at:
http://www.ayurveda.com/. Accessed November 5, 2002.
Roodenrys S, Booth D, Bulzomi S, et al. Chronic effects of Brahmi (
Bacopa monnieri) on human memory.
Neuropsychopharmacology.
2002;27:279 - 281.
Stough C, Lloyd J, Clarke J, et al. The chronic effects of an extract of
Bacopa monniera
(Brahmi) on cognitive function in healthy human subjects.
Psychopharmacology.
2001;156:481 - 484.
Nathan PJ, Clarke J, Lloyd J, et al. The acute effects of an extract of
Bacopa monniera
(Brahmi) on cognitive function in healthy normal subjects.
Hum Psychopharmacol.
2001;16:345 - 351.
Maher BF, Stough C, Shelmerdine A, et al. The acute effects of combined administration of
Ginkgo biloba
and
Bacopa monniera
on cognitive function in humans.
Hum Psychopharmacol.
2002;17:163 - 164.
Bharani A, Ganguli A, Mathur LK, et al. Efficacy of
Terminalia arjuna
in chronic stable angina: a double-blind, placebo-controlled, crossover study comparing
Terminalia arjuna
with isosorbide mononitrate.
Indian Heart J.
2002;54:170 - 175.
Gupta R, Singhal S, Goyle A, et al. Antioxidant and hypocholesterolaemic effects of
Terminalia arjuna
tree-bark powder: a randomised placebo-controlled trial.
J Assoc Physicians India.
2001;49:231 - 235.
Vaidya AB, Antarkar DS, Doshi JC, et al.
Picrorhiza kurroa
(Kutaki) Royle ex Benth as a hepatoprotective agent--experimental & clinical studies.
J Postgrad Med.
1996;42:105 - 108.
Sharma S, Bhargava R, Singhal K. Double blind study to assess the efficacy of in acute rhinitis.
Indian J Pharmacol.. 1990;22:103 - 105.
Shahani S, Dhadkar VN, Maroli S. The antihistaminic activity of Septilin and its role in topical eosinophillia
Indian J Pharmacol.
1993;25:114.
Rao CS, Raju C, Gopumadhavan S, et al. Immunotherapeutic modification by an ayurvedic formulation Septilin.
Indian J Exp Biol.
1994;32:553 - 558.
Koti ST. Evaluation of Septilin in persistent low-grade infections in school-children: a placebo-controlled study.
Sonda.
1992;31:325.
Agrawal A, Dubey M, Dubey G. Effects of Mentat on memory span, attention, galvanic skin resistance (GSR) and muscle action potential (EMG) among normal adults.
Pharmacopsychoecologia.
1990;3:39 - 42.
Dixit S, Agrawal U, Dubey G. Executive fatigue and its management with Mentat
Pharmacopsychoecologia.
1993;6:7 - 9.
Evaluation of BR-16 A (Mentat) in cognitive and behavioural dysfunction of mentally retarded children - a placebo-controlled study.
Indian J Pediatr.
1993;60:423 - 428.
Quadri AA. Mentat (BR-16A) in mentally retarded children with behavioral problems.
Curr Med Pract.
1993;37:121.
Patel RB, Pereira L. Experience with Mentat (BR-16A).
Probe.
1991;30:271.
D'souza, Chavda KB. Mentat (BR-16A) in hyperactivity and attention deficiency disorders - a double-blind, placebo-controlled study.
Probe.
1991;30:227.
Dayal RS, Kaira A, Misra MN. Role of Mentat (BR-16A) in behavioural disorders following postnatal organic lesions of the central nervous system (CNS).
Probe.
1991;30:305.
Sharma K, Kushwaha H, Sharma, S. A placebo-controlled trial on the efficacy of Mentat in managing depressive disorders.
Probe.
1993;33:26 - 31.
Banerjee S, Mukherjee A. Mentat (BR-16A) - A herbomineral preparation, as an adjuvant to conventionally used antiepileptic therapy reducing memory loss caused by electroconvulsive therapy (E.C.T).
The Ind Pract.
1994;47:929.
Shah LP, Patkar SA. Role of Mentat (BR-16A) in ECT-induced amnesia: A preliminary study.
The Ind Pract.
1993;3:225.
Ratna M, Abhijeet B, Mrudula A. Seizure control and pattern of behaviour in children with simple febrile convulsions - Effect of Mentat syrup.
The Ind Pract.
2001;54:729.
Agrawal A, Dixit, S, Dubey G. Role of Mentat in the management of post-stroke aphasia.
The Ind Pract.
1994;47:211 - 214.
Sharma AK, Agrawal A, Agrawal U, et al
.
Influence of Mentat (BR-16A) on memory and mental fatigue in cases of anxiety neurosis and depression.
Ind J Cancer Res.
1990;3:27.
Mani A, Indirabai K, Ramesh S, et al. Double-blind trial of Mentat (BR-16A) in enuresis.
The Antiseptic.
1993;90:538.
Das DG. A double-blind clinical trial of kamalahar, an indigenous compound preparation, in acute viral hepatitis.
Indian J Gastroenterol.
1993;12:126 - 128.
Saxena S, Garg AK, Jain A. Liv.52 in Infective Hepatitis. A study of Liv.52 therapy in infective hepatitis in children.
Current Medical Practice.
1980;5:194.
Sama SK, Krishnamurthy L, Ramachandran K, et al. Efficacy of Liv.52 in acute viral hepatitis. A double-blind study.
Indian J Med Res.
1976;5:738.
Mendal JN, Roy BK. Studies with Liv.52 in the treatment of infective hepatitis, chronic Active hepatitis and cirrhosis of the liver.
Probe.
1983;22:217.
Banerjee P, Mitra SR, Nandi M, et al. A preliminary report on clinical trial of Rumalaya on frozen shoulders.
Indian Med J.
1976;70:29.
Paranjpe P, Patki P, Patwardhan B. Ayurvedic treatment of obesity: a randomised double-blind, placebo-controlled clinical trial.
J Ethnopharmacol.
1990;29:1 - 11.
Kulkarni RR, Patki PS, Jog VP, et al. Treatment of osteoarthritis with a herbomineral formulation: a double-blind, placebo-controlled, cross-over study.
J Ethnopharmacol.
1991;33:91 - 95.
Mohan V. Evaluation of Diabecon (D-400) as an antidiabetic agent - A double blind placebo controlled trial in NIDDM patients with secondary failure to oral drugs.
Indian Journal of Clinical Practice.
1998;8:9,18.
Lalla JK, Nandedkar SY, Paranjape MH, et al. Clinical trials of ayurvedic formulations in the treatment of acne vulgaris.
J Ethnopharmacol. 2001;78:99 - 102.
Chatterjee S. Advances in the pharmacology of anti-infective therapy. International Symposium, Astra Zeneca Research Foundation and Intl. Society of Anti-Infective Pharmacology. 2000; Bangalore.
Dahanukar SA, Ogale SB. Paper under publication, Seth GS Medical College and KEM Hospital, Mumbai. 1999.
Biswas NR, et al. Dr. RP Centre for Opthalmic Sciences AIIMS, New Delhi. Paper presented at APPICON 1996.
Chopra A, Lavin P, Patwardhan B, et al. Randomized double blind trial of an ayurvedic plant derived formulation for treatment of rheumatoid arthritis.
J Rheumatol.
2000;27:1365 - 1372.
Vijayasarathy V, Sharma LK, Prakash ATM. Indigenous drug therapy for haemorrhoids.
The Med & Surg.
1981;1 - 2,22.
Vaishali N, Veena S, Dhar H, et.al. Double-blind comparative trial of Abana and methyldopa for monotherapy of hypertension in Indian patients.
Japanese Heart Journal.
1990;31:193.
Antani J, Kulkarni R, Antani N. Effect of Abana on ventricular function in ischaemic heart disease.
Japanese Heart Journal.
1990;31:829 - 835.
Damie VB, Gore AG. A controlled trial of Geriforte in post-menopausal depression.
The Ind Pract.
1982;35:21.
Patnaik BC, Misra SC. The evaluation of Geriforte as a general metabolic tonic in aged persons.
The Med & Sur.
1983;6:27.
Ganeriwal SK, Reddy BV, Baji PS, et al. The effect of geriforte on blood chemistry.
The Ind Pract.
1981;34:559.
Kulsreshtha JK, Handa RK. A clinical study on Geriforte.
The Ind. Pract.
1978; 5:247.
Gulbranson SH, Hud JA, Hansen RC. Argyria following the use of dietary supplements containing colloidal silver protein.
Cutis.
2000;66:373 - 374,376.
de Silva HA, Saparamadu PA, Thabrew MI, et al. Liv.52 in alcoholic liver disease: a prospective, controlled trial.
J Ethnopharmacol. 2003;84:47 - 50.
Tait PA, Vors A, James S, et al. Severe congenital lead poisoning in a preterm infant due to a herbal remedy.
Med J Aust. 2002;177:193 - 195.
La información aquí suministrada complementa la atención recibida por su médico. De ninguna forma intenta sustituir el consejo de un professional medico. LLAME A SU MEDICO DE INMEDIATO SI PIENSA QUE PODRIA TENER UNA EMERGENCIA. Siempre busque consejo médico antes de comenzar un nuevo tratamiento o si tiene preguntas sobre una condición médica.